🙌 A big thank you to all who joined us yesterday for our digital #WuXiGlobalForum!
In case you missed it, subscribe to our newsletter for insights into our BOLD online series, highlighting influential global thought leaders #TakingBOLDAction in the healthcare industry by:
✅ Breaking Barriers
✅ Opening New Horizons
✅ Leading Next Generation
✅ Delivering for Patients
Signup here: https://t.co/940KO9Rbv9
If you didn’t get a chance to attend the #WuXiGlobalForum during #JPM24, the online viewing will be available this Wednesday! Check out the panel, “Delivering on Platform Solutions,” featuring our cofounder and CIO Sabrina Yang.
https://t.co/iqSSecqkBA
#TakingBOLDAction
🎥 Tune in on WEDNESDAY at 7 AM or 7 PM PST to see prominent industry experts cover our industry's progress and the path toward catalyzing change for patients.
Don't miss out on the digital #WuXiGlobalForum! https://t.co/1QtTQpJE3v
As an integrated #testing platform across the full life cycle of discovery and development, WuXi Testing, one of the key business segments of WuXi AppTec, provides "end-to-end" testing services for novel drug developers and medical device manufacturers. With our wide-ranging expertise, we help our customers at every developmental stage, advancing their endeavors to bring life-saving products to patients in need.
Ready to see innovation in action? Watch the video for an exclusive one-minute glimpse into our meaningful work!
#DMPK #Bioanalytical #SafetyAssessment #ClinicalTrials #Innovation
Thank you to the thousands of friends and colleagues who joined us on Tuesday for our annual #WuXiGlobalForum at #JPM24. We’re immensely grateful to our distinguished panelists who shared their remarkable insights and expertise.
As a convener within the global healthcare community, we are truly inspired by the collaboration, innovative thinking, and wisdom shared.
#TakingBOLDAction will lead to real change for patients and families around the world.
🌟The 12th annual WuXi Global Forum is TODAY! 🌟
For those who are registered, we are excited to see you in San Francisco! Please get ready for insightful discussions, which start at 1:30 pm PST.
Learn more about today’s program and speakers here: https://t.co/aHR8cTJsy1
#WuXiGlobalForum #JPM24 #JPM2024
#JPMWeek is upon us, and we are thrilled to be in San Francisco for our 12th annual #WuXiGlobalForum tomorrow.
If you are as excited as we are, check out our list of distinguished panelists here: https://t.co/LEJBr0ViNT
We are delighted to announce the commissioning of two new #peptide#manufacturing plants, one at our Changzhou facility and another at the new Taixing site in China. This significant #expansion has increased our Solid-Phase Peptide Synthesis (SPPS) total reactor volume to 32,000 liters, addressing the surging global demand for peptide therapeutics.
At WuXi AppTec, we will continue to focus on enhancing our #CRDMO platform capability and capacity, accelerating innovative therapies to patients globally.
https://t.co/zVykcCyW9q
#WuXiGlobalForum 2024 is next week! 🎉
Learn more about our program and speakers: https://t.co/aHR8cTJsy1
Panels include:
✅ State of Innovation 2024
✅ Breaking Barriers. Leaping Forward.
✅ Opening Up New Horizons: Spotlight on Cancer
✅ Leading Transformation: The Next Wave Therapeutics
✅ Delivering on Future Platform Solutions
✅ Scaling Breakthroughs Forward
Bitterroot Bio CEO, @PavanCheruvuMD, to participate in a panel discussion at the 12th WuXi Global Forum: "Leading Transformation: The Next Wave Therapeutics" on January 9th in San Francisco. Learn more here: https://t.co/wGzRXTzDoA #JPM2024#WuXiGlobalForum#BitterrootBio
The countdown begins!
The 2024 #WuXiGlobalForum is less than 1 week away, and we are excited to celebrate during #JPM24. We will be joined by 30+ leading industry experts who will discuss the state of innovation in 2024 and beyond. Now in its 12th year, our annual forum seeks to strengthen global collaboration, inspire innovative thinking, and result in real change for patients and families across the world.
Special thanks to our supportive partners: @astar_research, @BIA_UK, @BioCentury, @biocom, @BioWorld, @CALifeSciences, @DavosAlzheimers, @endpts, @GENbio, @medicon_valley and @SwissBiotech.
Learn more about our program and speakers here: https://t.co/aHR8cTJsy1
#JPM2024 #JPMWeek
#WuXiGlobalForum 2024 is just around the corner! 🎉
We are honored that 30+ distinguished experts will be speaking at our 12th annual marquee event to thousands of industry representatives from around the world.
Panels include:
1. State of Innovation 2024
2. Breaking Barriers. Leaping Forward.
3. Opening Up New Horizons: Spotlight on Cancer
4. Leading Transformation: The Next Wave Therapeutics
5. Delivering on Future Platform Solutions
6. Scaling Breakthroughs Forward
Join us on January 9th as we come together to address some of the biggest challenges in our industry and work towards actionable solutions for patients around the world.
Learn more about our program and speakers: https://t.co/aHR8cTJsy1
#JPM24 #JPM2024 #JPMWeek
Warmest #Holiday wishes from WuXi AppTec! As we embrace this season of #reflection and #gratitude, we want to express our deepest appreciation to all of our customers, partners, and the healthcare industry for steadfastly supporting us throughout 2023. We are truly honored to work with you to make a meaningful impact to patients around the world.
May you and your loved ones enjoy a splendid holiday season with peace, joy, and prosperity. We look forward to another year of fruitful collaboration and shared achievements.
High throughput, unwavering precision, and consistent efficiency are three important factors in preclinical research. Take a closer look at how our Laboratory Testing Division continuously expands the platform and upgrades the #automation level of workstations to improve work #efficiency and the #quality of research data. We are proud to help customers expedite the drug development process, delivering ground-breaking therapies to patients faster.
Looking to the future, WuXi AppTec remains committed to embracing new capabilities and cutting-edge technologies, constantly pushing the boundaries of innovation.
👉 https://t.co/BO6VtI4t9S
#Lifescience #Innovation
Explore the comprehensive capabilities of WuXi Testing!
As a vital business segment of WuXi AppTec, WuXi Testing provides "end-to-end" testing services for novel drug developers and medical device manufacturers. Leveraging diverse expertise at every stage of development, we offer customers insights from extensive research data analytics needed for the R&D process and advance their endeavors to bring life-saving products to patients in need.
Enjoy the read, and stay tuned for more exciting progress updates! https://t.co/RVrpa7tv7I
#DMPK #Bioanalytical #SafetyAssessment #ClinicalTrials #Innovation
Now in its 12th year, the WuXi Global Forum will take place on January 9th, 2024 in #SanFrancisco during the 2024 J.P. Morgan Healthcare Conference. Global leaders and innovators will once again convene to catalyze new thinking on this global stage as we strive to advance breakthroughs faster for patients.
🎟️ #WuXiGlobalForum 2024 is complimentary and by invitation only. If you would like to participate in the conversations, please visit https://t.co/aHR8cTJsy1 to request a ticket.
#TakingBOLDAction #JPM24 #JPM2024 #JPMWeek #Healthcare #Biotechnology #Innovation
The #Middletown site will be WuXi STA, a subsidiary of WuXi AppTec's second facility in the United States, providing expanded capacity and greater flexibility to meet the needs of customers in the U.S. and around the world. Phase I of the new campus is expected to commence operations in 2025, offering services in formulation development, as well as clinical and commercial manufacturing of #oral solids.
Explore unbounded possibilities in drug development with @WuXi_Discovery! Our integrated discovery biology platform offers a full spectrum of services and solutions to support stand-alone and integrated projects, from target discovery to candidate selection and into the clinic. Through comprehensive capabilities, cutting-edge technologies, scientific excellence, expertise in all major areas, target classes and new modalities, we work collaboratively to deliver effective, flexible solutions to customers to accelerate their R&D process. Learn more about how we accelerate your research!
🔎 https://t.co/kDbDMhjHqf
#drugdevelopment #drugdiscovery #biology #biotech #biotechnology #newmodalties